Cargando…
The complement inhibitory protein DAF (CD55) suppresses T cell immunity in vivo
Decay-accelerating factor ([DAF] CD55) is a glycosylphosphatidylinositol-anchored membrane inhibitor of complement with broad clinical relevance. Here, we establish an additional and unexpected role for DAF in the suppression of adaptive immune responses in vivo. In both C57BL/6 and BALB/c mice, def...
Autores principales: | Liu, Jianuo, Miwa, Takashi, Hilliard, Brendan, Chen, Youhai, Lambris, John D., Wells, Andrew D., Song, Wen-Chao |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213052/ https://www.ncbi.nlm.nih.gov/pubmed/15710649 http://dx.doi.org/10.1084/jem.20040863 |
Ejemplares similares
-
Discovery, linkage disequilibrium and association analyses of polymorphisms of the immune complement inhibitor, decay-accelerating factor gene (DAF/CD55) in type 1 diabetes
por: Taniguchi, Hidenori, et al.
Publicado: (2006) -
Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas.
por: Koretz, K., et al.
Publicado: (1992) -
The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF)
Publicado: (1996) -
Efficient destruction of human immunodeficiency virus in human serum by inhibiting the protective action of complement factor H and decay accelerating factor (DAF, CD55)
Publicado: (1996) -
Equilibrium and Kinetics of Sin Nombre Hantavirus Binding at DAF/CD55 Functionalized Bead Surfaces
por: Buranda, Tione, et al.
Publicado: (2014)